Physician Dr Marius Wasserfall is warning the public against using unlicensed, counterfeit drugs that have been found to ...

Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal with the Trump administration to drop prices for customers. The Wegovy ...

The 'Dancing with the Stars' contestant lost 20 lbs. from a GLP-1 medication but stopped taking it after experiencing ...

The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish ...

Last year, the U.S. Food and Drug Administration banned the sale of compounded weight loss drugs, which are often much ...

"Developing new ways to treat these patients is of the utmost importance," Dr. Casey H. Halpern, a senior author of the study ...

The results show the treatment's potential to mitigate GLP-1 induced nausea and vomiting, which are key factors for those who stop using weight-loss drugs, Vanda Chief Executive Mihael Polymeropoulos ...

The new generation of obesity medications are inducing greater weight loss than any prior pharmacotherapy. There is discussion now about how to support fat loss while protecting lean mass.“Lean mass ...

A GLP-1/glucagon dual agonist induced significant weight loss and improved multiple cardiometabolic parameters for adults ...

A banned weight-loss drug with dangerous cardiac side-effects is being marketed to young people as a natural supplement on ...